Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Octreotide Acetate Injection

Approval Number

国药准字H20133091

Company苏州天马医药集团天吉生物制药有限公司

Registration Date

September 20, 2022

Previous Approval Numbers

国药准字H20133091

Drug Information

Generic Name

醋酸奥曲肽注射液

Dosage Form

注射剂

Strength

1ml:0.2mg(按C49H66N10O10S2计)

Drug Type

化学药品

Registration Date

September 20, 2022

Company Information

Applicant Company

Company Name苏州天马医药集团天吉生物制药有限公司

Company Address

苏州市吴中区木渎镇花苑东路199号

Manufacturing Company

Company Name苏州天马医药集团天吉生物制药有限公司

Company Address

苏州市木渎镇花苑东路199号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy